NCT01873508 A Study of Three Modified-Release Formulations of RO4917523 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01872689 A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT01871805 A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1/PHASE2
NCT01871428 A Study of Aleglitazar in Monotherapy in Patients With Type 2 Diabetes Mellitus Who Are Drug-Naïve to Anti-Hyperglycemic Therapy Status COMPLETED Phase PHASE3
NCT01871415 A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy Status COMPLETED Phase PHASE3
NCT01868061 A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication Status COMPLETED Phase PHASE3
NCT01867125 A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication Status COMPLETED Phase PHASE3
NCT01866150 A Retrospective, Observational Chart Review of Biologics in Monotherapy Versus the Combination Biologic Plus Methotrexate in Patients With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01864226 A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO5545965 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01863693 An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1) Status COMPLETED Phase N/A
NCT01861444 An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a) Status TERMINATED Phase N/A
NCT01860638 A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma Status COMPLETED Phase PHASE2
NCT01855997 A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue Status COMPLETED Phase N/A
NCT01855789 A Study of the Impact of Methotrexate (MTX) Discontinuation on the Efficacy of Subcutaneous (SC) Tocilizumab (TCZ) With MTX Status COMPLETED Phase PHASE3
NCT01853254 A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials Status COMPLETED Phase PHASE3
NCT01851824 A Study of the Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy Status COMPLETED Phase PHASE1
NCT01849666 A Study of the Effect of Vemurafenib on the Pharmacokinetics of Phenprocoumon in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy Status COMPLETED Phase PHASE1
NCT01844674 A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies Status COMPLETED Phase PHASE1
NCT01839500 A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer Status COMPLETED Phase N/A
NCT01836133 An Observational Study of Tarceva (Erlotinib) in Participants With Locally Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer (ELEMENT) Status COMPLETED Phase N/A